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Allergies à la Carte
Is There a Problem
with Genetically
Modified Foods?
What’s in a name? Ask genetically modi-
fied (GM) foods. They go by many
names, ranging from the sinister
(“Frankenfoods”) to the adoring
(“super crops”), depending
on who’s doing the nam-
ing. Although there are
clear benefits to the
use of this tech-
nology—for
example, genet-
ic modification
could reduce the
amount of allergenic
substances in foods
such as peanuts,
the most common
food allergen—
there is also growing
concern among the
general public about
whether foods modified
by recombining DNA
from widely different
organisms are safe.
A conference titled
“Assessment of the
Allergenic Potential of
Genetically Modified
Foods,” organized and
sponsored by the
National Toxicology
Program, the U.S.
Environmental Protect-
ion Agency, the U.S. Food
and Drug Administration
(FDA), and the NIH, was held
10–12 December 2001 in Chapel
Hill, North Carolina, to address this
question. Clinicians, bench scientists,
government regulators, industry per-
sonnel, and policy analysts summarized
the current state of the knowledge, exam-
ined the issues, and made recommenda-
tions for setting research priorities to
improve risk assessment.
GM foods are products of plants engi-
neered by biotechnology (no GM animal
products are currently approved for the U.S.
market). GM crops contain either genes
from other plant, animal, or bacterial species,
or modified genes constructed in the labora-
tory and not found in nature. These “bor-
rowed” genes confer some advantage such as
pest resistance, herbicide tolerance, longer
shelf life in the supermarket, or increased
nutritional value. 
One unanswered human health question
concerns allergenicity. GM foods often con-
tain proteins that humans may not have
ingested before or that they may have
encountered in a different context (for exam-
ple, as a glycosylated protein in the original
plant but as a nonglycosylated protein in a
GM food). Might such novel proteins cause
allergic reactions in genetically predisposed
people? 
Reason for Concern?
In his keynote address, Dean Metcalfe,
chief of the Laboratory of Allergic Diseases
at the National Institute of Allergy and
Infectious Diseases, explained that an aller-
gic reaction is a complex immune system
response to an antigen—a protein or piece
of a protein that is recognized by the
immune system as a potential allergen.
Antigens come from foreign proteins found
in substances such as food, fungi, bacteria,
viruses, pollen, and cells from transplanted
tissues. They trigger the production of anti-
bodies, which protect the body by neutral-
izing the “invader.” 
The immune response gen-
erally provides protection
against foreign substances. In
genetically predisposed
individuals, however,
exposure to certain pro-
teins may cause an over-
reaction to an ordinarily
innocuous substance. A
later reaction between
the antigen and the
antibody releases
chemicals that
affect many dif-
ferent tissues,
causing symptoms
ranging from minor
skin rashes, head-
aches, vomiting, and
diarrhea, to, in rare
instances, anaphylaxis
and death. 
Metcalfe emphasized
that the mechanisms
involved in allergic
reactions are highly
complex because of
their interdependen-
cy on other molecu-
lar conditions in both
the body and the envi-
ronment. For example, a
person may have an aller-
gic response to a food only
when there is also some kind of
infection present. People can also
develop tolerance or sensitivity to
different allergens depending on their
exposure and stage of physical develop-
ment. Babies and children are more prone
to allergies because of their immature
immune systems. Children are not born
with the ability to tolerate food proteins; as
they are weaned and begin to eat food, they
gradually develop tolerance to food proteins.
Approximately 80% of children with aller-
gies outgrow them at some point.
In the United States, around 7 mil-
lion people have documented food aller-
gies. A Mayo Clinic study published in
the August 1999 (part 1) issue of the
Journal of Allergy and Clinical
Immunology showed that a third of the
cases of anaphylaxis in the United States
were due to food allergies, whereas a
A 130 VOLUME 110 | NUMBER 3 | March 2002 • Environmental Health Perspectives
NIEHS News
M
a
t
t
 
R
a
y
/
E
H
PBritish study published in the
December 1996 issue of Clinical and
Experimental Allergy showed 50% of the
cases in England were caused by food
allergies (a discrepancy that may be due
to study design). There are 150–175
deaths per year from food allergy reac-
tions in the United States. The majority
of people who die from food allergies
also have asthma.
The only treatment for food allergies
is dietary avoidance, which depends
upon being able to identify the source of
exposure and treat reactions should they
occur. This defines the central problem
in regard to the safety of GM foods:
because GM foods are not currently
labeled, it is impossible to know whether
the produce one buys at the supermarket
contains possibly allergenic transgenic
proteins. 
Many scientists believe GM food safe-
ty could be well characterized by clinical
trials using double-blind food challenge
tests in which subjects sample foods under
immediate medical supervision. However,
such tests are not routinely conducted on
GM foods. 
Determining Allergenicity
Three criteria are currently used to
determine if a transgenic protein is safe
for human consumption. First, a
sequence comparison to food proteins
known to elicit allergic reactions is con-
ducted to see whether the novel protein
has a linear sequence of amino acids
similar to known allergens. Scientists
then test the reaction of antibodies to
known food antigens in the new food.
Finally, they run test tube assays to
determine how well a protein with-
stands digestion. These same criteria
can be useful for crops produced by
more conventional agricultural cross-
breeding as well. But questions remain
as to the effectiveness of these methods
for assessing the safety of foods with
novel proteins.
The bioinformatic tools and data-
bases available to compare sequence
homology were developed to look at
evolutionary relationships between dif-
ferent organisms. In predicting aller-
genicity, the critical questions involve
much more subtle differences within
organisms that are not necessarily
revealed by available computer pro-
grams and search engines. One issue is
that there is no standardization of how
many amino acids should be looked for
in a sequence. The fewer the number of
amino acids in the sequence search, the
more possible matches, and many of
those matches may not be valid indica-
tors of allergenicity. On the other hand,
the greater the number of amino acids
in the sequence search, the higher the
likelihood of missing a sequence that
may cause a problem. The question is
determining the optimal number of
search sequences.
Robert Hamilton, director of the
Johns Hopkins Dermatology, Allergy,
and Clinical Immunology Reference
Laboratory, pointed out that another
problem with the comparison of the
primary amino acid structure to pro-
teins already in databases is that allergic
reactions often arise while or after pro-
teins are metabolized. In such cases, this
technique could not reveal allergenic
potential. 
Research scientist Tong-Jen Fu of
the FDA’s National Center for Food
Safety and Technology discussed the
reliability of digestion assays for deter-
mining food safety. This concept
assumes that all or most food allergens
resist digestion more than other foods.
This is not necessarily a safe assumption
to make; although many food allergens
are indeed stable during digestion,
many other major allergens are broken
down by gastric enzymes, and these
cannot be detected in the digestion
stability assays. Also, due to a lack of
standardization, there is considerable
variability in results from different labo-
ratories that use different ratios of
enzymes to test proteins in their diges-
tion assays. Furthermore, because in
vitro tests use much higher amounts of
enzymes than what is found in the
human digestive tract, these assays do
not simulate what actually occurs in
human digestion. 
The Future of GM Foods
Although GM foods may offer great
benefits, certain concerns must be
assuaged before these foods can be
accepted as a net gain. Current methods
for assessment have not been validated
as robust indicators of safety; alternative
strategies including animal models and
immunoassays need to be developed.
The clear identification and articulation
of the challenges posed by widespread
deployment of novel proteins in our
food supply is a vital step toward
improving risk assessment and prevent-
ing adverse health effects that could
arise from eating GM foods. 
In an upcoming issue, EHP will
publish a mini-monograph resulting
from research presented at this meeting.
–Mary Eubanks
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Introducing an itch? Speakers at a recent conference on genetically modified foods debated
whether transgenic crops might result in allergic reactions in susceptible populations.The Current of 
Red Tide Research 
An interdisciplinary group of scientists
from federal and state government, aca-
demic, and research institutions have
completed the first phase of data collec-
tion for human exposure to aerosolized
brevetoxins during red tide events.
Brevetoxins are potent neurotoxins pro-
duced by the dinoflagellate Karenia
brevis (previously classified as Gymno-
dinium breve), a marine microalga
found in the Gulf of Mexico
and the western North
Atlantic. The first portion of
this study, known as the 2001
Occupational Red Tide
Survey, is being funded by the
Florida Department of Health,
the Centers for Disease
Control and Prevention
(CDC), the Florida Harmful
Algal Bloom Taskforce, and
the NIEHS. The group is
being led by Daniel Baden,
director of the Center for
Marine Science at the
University of North Carolina
at Wilmington, and Lorrie
Backer, leader of the CDC’s
Emerging Environmental
Threats Team.
On an almost annual basis, K. brevis
forms large toxic blooms, known as red
tides, particularly along the west coast
of Florida. An extensive bloom of K.
brevis red tide such as the one present in
Florida since late in the summer of
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Overstaying its welcome. A K. brevis red tide has plagued the Gulf of Mexico since August 2001—the dark, cloudy areas near the shoreline show
where the bloom lingers. The dinoflagellate K. brevis (inset) is implicated in health problems in humans as well as marine mammals and birds, includ-
ing respiratory and neurotoxic effects.
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Measuring mammals. Researchers perform spirometry on
red tide–afflicted manatees to detect respiratory effects.2001 can kill tons of fish. Marine mam-
mals (such as the highly endangered
West Indian manatee) and birds also
succumb to the respiratory paralysis and
other neurotoxic effects caused by expo-
sure to brevetoxins. 
One recognized human health effect
from exposure to K. brevis and its toxins
is neurotoxic shellfish poisoning (NSP),
which can occur when people eat shell-
fish that have been contaminated
through filter-feeding activities. NSP
can be prevented by monitoring waters
for K. brevis and rapidly closing shell-
fish beds when blooms approach; in the
United States, the only reported cases
of NSP in about 30 years have been
from the consumption of shellfish col-
lected illegally from closed beds. 
In addition to NSP, people have
reported a number of symptoms,
including respiratory complaints, after
being on or near the beach during a red
tide event. Although a link has not been
scientifically and medically demonstrat-
ed, scientists believe these symptoms are
caused by exposure to aerosolized breve-
toxins and perhaps airborne K. brevis
cellular debris generated during red tide
events. 
During the K. brevis bloom that
formed in August 2001 in the Gulf of
Mexico, the research team collected
water for K. brevis cell enumeration and
for brevetoxin concentrations, collected
air samples for brevetoxin concentra-
tions, and monitored meteorologic con-
ditions. The team also monitored the
incidence of human health effects asso-
ciated with red tide events. Specifically,
pre- and postexposure information on
pulmonary function and inflammatory
response as well as respiratory symptoms
was collected from a group of lifeguards
stationed at the affected beaches and
from some of the scientists collecting
environmental samples. Preliminary
results will be presented at the 2002
annual meeting of the Society of
Toxicology to be held this month. 
In the future, scientist collaborators
will return to this area to collect similar
human health and environmental data
on the same individuals during a time
when there is no red tide event. The
scientists also plan to evaluate the
health effects from exposure to red tide
in people visiting beaches, particularly
sensitive populations such as those with
asthma and older people with chronic
respiratory problems. In addition,
ongoing studies are using experimental
animals to evaluate both mechanisms
and possible prevention of exposure to
and health effects of the aerosolized
brevetoxins associated with K. brevis red
tides. –Red Tide Research Group
Environmental Health Perspectives • VOLUME 110 | NUMBER 3 | March 2002 A 133
NIEHS News
On the lookout for trouble. A member of the 2001 Occupational Red Tide Survey team collects
lung function and respiratory effect data from a lifeguard who worked on beaches affected by K.
brevis red tides.
National Oceanic and
Atmospheric Administration
http://state-of coast.noaa.gov/
bulletins/html/hab_14/hab.html
Woods Hole Oceanographic
Institution
http://www.agu.org/revgephys/
anders01/anders01.html 
International Society for the
Study of Harmful Algae
http://www.cbr.nrc.ca/issha/
Florida Marine Research Institute
http://www.floridamarine.org/
Mote Marine Laboratory
http://www.mote.org/
Northwest Fisheries Science
Center
http://www.nwfsc.noaa.gov/hab/
University of Miami NIEHS
Marine and  Freshwater
Biomedical Sciences Center
http://www.rsmas.miami.edu/
groups/niehs/
National Marine Fisheries Service
http://www.sh.nmfs.gov/
EAquaBpg.htm
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Harmful Algal Bloom
Web Sites